MR 7700 Multinuclear Application Clinical Trial
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorPhilips Clinical & Medical Affairs Global
About this trial
The purpose of this clinical trial is to use the medical magnetic resonance imaging system MR 7700 to perform phosphorus (31P) and sodium (23Na) scanning imaging on the human body, evaluate the image quality of phosphorus (31P) and sodium (23Na) scanning, as well as the machine convenience, machine stability, and system safety of the entire system.
Eligibility criteria
Qualifiers
• 18 ≤ Age ≤ 75 years old;
Clear mind, able to cooperate, and capable of autonomous behavior;
Voluntarily agree to participate in this clinical trial and sign the informed consent form for the subjects
Disqualifiers
• Individuals with claustrophobia.
On the day of scanning, the subject's body temperature was above 39.5 ℃.
Plan to become pregnant, pregnant, and breastfeeding women within 6 months.
Other implants, prostheses, foreign bodies, patches, etc. that are not suitable for magnetic resonance imaging examination; There are electronic implants such as pacemakers, stimulators, insulin pumps, cochlear implants, etc.
Trial design
Treatments tested in this trial
- MR Scanning with Phosphorus nucleus + Sodium nucleus
Treatment groups
200 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov